Neurocern

At Neurocern, we use an “expert system” (a type of artificial intelligence) to connect fragmented health data and enrich it for actionable insights to improve health and financial outcomes — but what does that mean, really? Check out our latest blog post — written by Neurocern CTO Mark Wiendling — for a deep dive into different types of AI and how an expert system stacks up: bit.ly/3qVL2gR

We’re excited to announce that Neurocern's technology successfully demonstrated more than $370M in savings for Medicare and health insurance claims related to Alzheimer's disease drug eligibility. In a first-of-its-kind approach, Neurocern’s AI engine used predictive data modeling and advanced analytics to identify and triage patients to the right Alzheimer’s disease modifying therapy at the right time, thereby getting patients to treatments faster and saving insurers and the consumer millions in costs. Read the full press release: bwnews.pr/3Iws0pj

Anitha Rao Capco Diameter Health

Join us for grand rounds this week as our Founder, Dr. Anitha Rao, discusses how artificial intelligence and data analytics can be used to create patient cohorts, identify patients for high utilization, and flag patients most likely to meet drug eligibility at the individual and population level. Register here: https://www.eventbrite.com/e/leveraging-artificial-intelligence-data-to-improve-neurological-outcomes-registration-209511383187

Leveraging Artificial Intelligence & Data to Improve Neurological Outcomes University of Toledo College of Medicine, Department of Neurology Grand Rounds

Data is king. How will Biogen’s Alzheimer’s drug impact the Medicare Supplement market? Neurocern’s AI-driven analytics can create actionable insights for Medigap underwriting, claims, and risk management. Join us at the 2021 Medicare Supplement Conference in Chicago on September 9 to hear from our founder, Dr. Anitha Rao, on how Neurocern’s predictive analytics detect cognitive impairment using Medicare supplement data. Read more on our blog: http://bit.ly/3Dy9uKG

Did you know one in three Medicare patients have had at least one office visit for a neurological condition? Access to neurological specialists is limited across much of the United States. Neurocern recently partnered with Milliman and the Society of Actuaries to explore the relationship between access to neurologists and the incidence of long-term care insurance cognitive claims. Read more on our blog at https://bit.ly/3vEEDa9 and use Neurocern to understand symptoms and find the right specialist based on your cognitive needs by starting a Neuro Health Intake at https://intake.neurocern.com.